Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$14.80 0.37 (2.56%)
2/9/2010 4:00 PM

Luminex Corp (LMNX)

CAPS Rating:
**

The COmpany develops, manufactures and sells proprietary biological testing technologies with applications throughout the life sciences industry.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating LMNX

Add Stock to Watchlist

What the Community Thinks

Total Members

92 Outperforms
18 Underperforms
 

All-Stars

23 Outperforms
7 Underperforms
 

Wall Street

7 Outperforms
0 Underperforms
 

Members bullish on LMNX are also bullish on:

Members bearish on LMNX are also bearish on:

Ticker Tags

Small Cap (1645), Molecular Diagnostics (3), Healthcare (711), Life Sciences Tools and Services (53), Defensive (1457), Supplies (52), Growth (1902)
Suggest a tag

Luminex Corp At A Glance

Current Price: $14.80
Last Trade Time: 2/9/2010 4:00 PM
Open: $14.58
Previous Close: $14.43
Daily Range: $14.19 - $14.85
52-Week Range: $12.75 - $21.35
Volume: 314,481
Market Cap: $618.61M
P/E Ratio: 80.17
Compare Our Special Broker Offers!

Stock Trends

LMNX VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Luminex Corp (LMNX)

Avatar LeoGetz (35.99) Submitted: 2/18/09 3:14 PM

This stock looks like it has support around $18.50 plus the daily stochastics are at the very bottom. The risk to reward seems great on this one. Wish me luck.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Luminex Corp (LMNX)

Avatar MICAHMOM (< 20) Submitted: 10/15/06 9:25 AM

Its diversified holdings of precious metals and fossil fuel should help it perform well despite the down tick after the US elections many other stock will experience.

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 12 :   1 2 3 Next »

Show Pitch Replies

Recs

0

 (LMNX)

Avatar JerryDreamer (< 20) Submitted: 8/17/09 1:36 AM : Underperform Start Price: $15.81 LMNX Score: 15.38

When the overly optimistic FOMC says that household spending will be "constrained" by sluggish income growth, ongoing job losses, lower household wealth, and tight credit AND Shanghai stocks hit a seven-week low, then you know this bear market rally is finally over!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LMNX)

Avatar JPG101 (91.96) Submitted: 8/04/09 1:28 AM : Outperform Start Price: $14.26 LMNX Score: 27.18

A small company with a market cap bellow 1 billion who sits at the center of an industry with its flow cytometry patents and technology. The list of their partners is truely impressive. This is a platform technology company who licences its tech to so many companies that it's difficult to keep track. Luminex is extremely well positioned to ride the wave of diagnostic upgrades that our medical system will eventually need to do. Many of the clinical tests we do are time consuming, labour intensive and slow. The current uncertainty in the health care market makes short term predictions about this and so many other diagnostic companies difficult but the significant funds unlocked as part of the stimulus package will certainly be a big accelerator for the research market that Luminex serves. The market seems to have partailly priced in the effect of the stimulus package for companies like Illumina, Life, Affymetrix and Luminex but might have overlooked the long term advantage that first movers can have in science diagnostics. Companies that are well positioned to sell their machines now might be 'locking in' for a significant amount of time. Their research platforms could become standards for a relatively long time. Research plateforms could also become stepping stones to the clinical market.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (LMNX)

Avatar LeoGetz (35.99) Submitted: 2/18/09 3:14 PM : Outperform Start Price: $18.97 LMNX Score: -59.70

This stock looks like it has support around $18.50 plus the daily stochastics are at the very bottom. The risk to reward seems great on this one. Wish me luck.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LMNX)

Avatar CBombay (30.06) Submitted: 2/18/09 3:07 PM : Outperform Start Price: $18.97 LMNX Score: -59.87

I need this revenue grower to fill the "Long" void in my portfolio. Technically set for a short-term gain.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (LMNX)

Avatar qksand (< 20) Submitted: 11/27/08 10:04 AM : Outperform Start Price: $22.60 LMNX Score: -58.63

help doctors identifying the virus helps the patient - add value and minimize waste !

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 12 :   1 2 3 Next »

Wall Street

Results 1 - 7 of 7  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackWedbush 66.12 05/08/09 Outperform NS $15.22-2.76%+17.47%-20.22
TrackGlobalCrown < 20 11/07/08 Outperform NS $20.44-27.59%+20.05%-47.64
TrackGarpResearc 82.69 02/01/08 Outperform NS $15.12-2.12%-18.99%+16.88
TrackAvondale 87.18 01/16/08 Outperform NS $17.13-13.60%-18.89%+5.29
TrackCanaccord 86.15 09/11/07 Outperform NS $14.85-0.34%-23.19%+22.85
TrackTWeisel < 20 03/20/07 Outperform NS $13.82+7.09%-19.08%+26.17
TrackSoleil 93.91 12/11/06 Outperform NS $13.48+9.79%-19.53%+29.32

Results 1 - 7 of 7  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 359ms